Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| CGM & insulin pump management · New York | CGM & insulin pump management · New Jersey | |
|---|---|---|
| Surgeons, 2024 | 496 | 303 |
| Medicare fee-for-service cases | 58,834 | 39,418 |
| Growth since 2019 (Medicare FFS) | +16%/yr | +16%/yr |
| Forecast cases (Medicare FFS) | 98,600 in 2030 | 69,600 in 2030 |
| Forecast growth | +9%/yr to 2030 | +10%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 31.7 | 37.1 |
| Medicare Advantage share | 57% | 45% |
| Out of hospital | 89% (−5 pts since 2019) | 99% (−1 pts since 2019) |
| Cases per surgeon | 119 | 130 |
| Top 10 surgeons' share | 17% | 20% |
| Surgeons growing | 174 | 130 |
| New since the base year | 215 | 117 |
| Likely to stop billing it | 19 by 2026 | 17 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,578 | $1,916 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.